BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11366565)

  • 21. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
    Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soaring prices, soaring sales.
    Grinberg L
    GMHC Treat Issues; 1998 Dec; 12(12):5-7. PubMed ID: 11366020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C.
    Wright IA
    Gastroenterol Nurs; 2000; 23(6):275-80. PubMed ID: 11854972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
    Sulkowski MS; Wasserman R; Brooks L; Ball L; Gish R
    J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of the HCV/HIV-coinfected patient.
    Sherman KE
    AIDS Clin Care; 2002 May; 14(5):39-43, 48. PubMed ID: 12004876
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
    Chevaliez S; Brillet R; Lázaro E; Hézode C; Pawlotsky JM
    J Virol; 2007 Jul; 81(14):7732-41. PubMed ID: 17494069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
    Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperthyroidism with interferon-ribavirin therapy for hepatitis C: a case report and proposed treatment algorithm.
    Harris DM; Hespenheide EE; Dalkin AC; Kirk SE; Ellis DS; Caldwell SH
    Am J Gastroenterol; 2000 Oct; 95(10):2995-6. PubMed ID: 11051394
    [No Abstract]   [Full Text] [Related]  

  • 32. Product information.
    Bartlett JG
    Hopkins HIV Rep; 1999 Mar; 11(2):6-7. PubMed ID: 11366250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy action fuels drug-marketing debate.
    Gaylord G
    Posit Living; 1999 Aug; 8(7):15, 23. PubMed ID: 12492077
    [No Abstract]   [Full Text] [Related]  

  • 34. Ribavirin.
    Al Knawy B
    Saudi J Gastroenterol; 2001 Jan; 7(1):42-3. PubMed ID: 19861767
    [No Abstract]   [Full Text] [Related]  

  • 35. Ribavirin.
    Hall CB
    Infect Dis Newsl (N Y); 1985 Oct; 4(10):73-75. PubMed ID: 32336861
    [No Abstract]   [Full Text] [Related]  

  • 36. Ribavirin for hepatitis C: 80% price reduction available July 9?
    James JS
    AIDS Treat News; 1999 Jul; (No 322):3-4. PubMed ID: 11366565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribavirin approved with a big fat price.
    Falkenberg J
    Notes Undergr; 1998; (No 37):10-1. PubMed ID: 11365818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marketing scam spoils hep C treatment.
    Proj Inf Perspect; 1998 Dec; (26):6. PubMed ID: 11366498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V; Kostman JR
    AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.